These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27920085)

  • 1. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
    Paton C; Bhatti S; Purandare K; Roy A; Barnes T
    BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
    Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
    J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.
    Barnes TR; Banerjee S; Collins N; Treloar A; McIntyre SM; Paton C
    Br J Psychiatry; 2012 Sep; 201(3):221-6. PubMed ID: 22790679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK.
    Barnes TR; Bhatti SF; Adroer R; Paton C
    BMJ Open; 2015 Oct; 5(10):e007633. PubMed ID: 26428329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POMHS 9b - antipsychotic prescribing in people with a learning disability.
    Thalitaya MD; Udu V; Nicholls M; Clark T; Prasher VP
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S50-6. PubMed ID: 21894103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
    Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
    J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the prescribing observatory for mental health.
    Barnes TR; Paton C
    Br J Psychiatry; 2012 Dec; 201(6):428-9. PubMed ID: 23209087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study.
    Sheehan R; Horsfall L; Strydom A; Osborn D; Walters K; Hassiotis A
    BMJ Open; 2017 Aug; 7(8):e017406. PubMed ID: 28775195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of antipsychotics in people with intellectual disability.
    Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
    Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards of lithium monitoring in mental health Ttrusts in the UK.
    Collins N; Barnes TR; Shingleton-Smith A; Gerrett D; Paton C
    BMC Psychiatry; 2010 Oct; 10():80. PubMed ID: 20939864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
    Abrams TE; Lund BC; Bernardy NC; Friedman MJ
    Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services.
    Paton C; Crawford MJ; Bhatti SF; Patel MX; Barnes TR
    J Clin Psychiatry; 2015 Apr; 76(4):e512-8. PubMed ID: 25919844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic prescribing in nursing homes: an audit report.
    Morrison A
    Qual Prim Care; 2009; 17(5):359-62. PubMed ID: 20003722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of antipsychotic prescribing in a private psychiatric hospital.
    Botvinik L; Ng C; Schweitzer I
    Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological management of acute behavioural disturbance: Data from a clinical audit conducted in UK mental health services.
    Paton C; Adams CE; Dye S; Fagan E; Okocha C; Barnes TR
    J Psychopharmacol; 2019 Apr; 33(4):472-481. PubMed ID: 30565486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic long-acting injections: prescribing practice in the UK.
    Barnes TR; Shingleton-Smith A; Paton C
    Br J Psychiatry Suppl; 2009 Nov; 52():S37-42. PubMed ID: 19880915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.